Showing 7451 - 7460 of 7715 for "Trade mark" with applied filters
Filters:
28 April 2023 by Ana-Maria Baciu
Ana-Maria Baciu talks about setting up her own firm, Simion & Baciu, and recent client matters
25 April 2023 by Alexandra Dellmeier
Alexandra Dellmeier of LexDellmeier Intellectual Property Office talks about her career in IP and running her own firm
21 April 2023 by Otto Licks and Rodrigo Maior (Licks Attorneys)
Otto Licks and Rodrigo Maior of Licks Attorneys explains why Brazil is important to patent portfolio strategy
29 March 2023 by Roberto Rodrigues Pinho and Ricardo Campello (Licks Attorneys)
Ricardo Campello of Licks Attorneys analyses Brazil's legislation and regulation concerning skinny labelling
11 January 2023 by Licks Attorneys
The healthcare sector in Brazil is one of the most important in the world in view of the size of the population (+220 million people) and the availability of a universal public healthcare system. The action of antibodies as therapeutic agents may involve processes of neutralization, opsonization and activation of immune complement system, transforming them into a progressively desirable tool in medicine. In view of this, the interaction between IP and these innovative therapies deserves special attention.
01 December 2022 by Licks Attorneys - Brazil
Licks Attorneys announced the promotion of two attorneys at law to partners
19 October 2022 by Anand and Anand
In a case involving Bridgestone, Delhi High Court interpreted the Indian law relating to international applications under the Madrid Protocol
14 February 2022 by LexOrbis
Manisha Singh and Niti Vyas of LexOrbis consider the findings of a Delhi High Court case that looks at how registered trademarks are used as keywords
04 January 2022 by Managing IP
Christine Kanz of Hoyng Rokh Monegier in Germany talks about her career in IP law, what she learned from a recent client matter, and life outside work
01 September 2021 by Manisha Singh and Pankaj Musyuni
Manisha Singh and Pankaj Musyuni of LexOrbis discuss how patent rights are impeding access to medicines and what can be done to minimise the damage caused by COVID-19
